Semantic Search explained (in short and not so short) http://goo.gl/02j0fi

Janaina Medeiros
dirt enthusiast
art blog(derogatory)

JVL

No title available
Keni
Not today Justin
Show & Tell
Lint Roller? I Barely Know Her
wallacepolsom
RMH

Origami Around
Aqua Utopia|海の底で記憶を紡ぐ
Peter Solarz
I'd rather be in outer space 🛸
TVSTRANGERTHINGS

Love Begins
let's talk about Bridgerton tea, my ask is open
AnasAbdin
will byers stan first human second
seen from Dominican Republic

seen from Türkiye
seen from Türkiye
seen from United States
seen from United States
seen from United States
seen from United States
seen from United States
seen from United States
seen from Portugal
seen from United States
seen from United States
seen from United States

seen from France

seen from Tunisia
seen from Malaysia
seen from Malaysia
seen from Singapore

seen from United States

seen from Malaysia
@ontoforce
Semantic Search explained (in short and not so short) http://goo.gl/02j0fi
Explaining semantic search (in short and not-so-short)
This is a question I get quite often: what is semantic search? I’ll give you the short and not-so-short answer. As well as some possible applications which we’ve included our own semantic search platform.
Semantic search in short
In short: semantic search extends the current search possibilities by looking at 1) the intent of the searcher as well as 2) the context within which the search takes place. When properly combined, you get more refined and better attuned search results.
OK, that makes sense. But when you do this on the general web, the task of uncovering intent and context becomes quite challenging. Imagine you’re planning a business trip to Paris. You go to Google and type in the keywords ‘Paris’ + ‘Hilton’, only to get dozens of celebrity pages. You’ll have to refine your keyword string (no pun intended!) to get to the actual Paris branch of the hotel chain.
And yes, Google is already making some assumptions and offers you some additional keywords to try and understand your intention better, but much of that is still after the fact.
Semantic search, not-so-short
Semantic search becomes a lot more actionable when you place it in a pre-defined context, such as an industry or a company. Instead of offering ‘best guesses’, the search technology can more quickly make assumptions about intent and context and fine tune the results accordingly.
Consider an R&D-driven industry like life sciences. What we do there, is connect different data sources (open and closed public data, internal and third party data) and tie it all together. We create an ontology, by which we mean that different descriptions for the same thing are given a unique identifier. So the system knows that ‘male’ is the same as ‘m’, is the same as ‘masculine’, and so on. That way, data from an unlimited number of different data sources can be compared and meaningful results can be generated. The strength of semantic search is that it can do this for an unlimited number of categories.
Semantic search and Big Data
In this way, semantic search overcomes the 4 Vs of Big Data: volume, velocity, variety and veracity. Making connections between ever-growing mountains of data and widely differing data sources is fueling the need for semantic search.
With semantic search, it doesn’t matter how many different databases you search in. The system will make the corresponding links between the bits of information and present it in a meaningful manner to you.
Semantic search reveals unexpected connections between your search query and different data sources. Consequently, it retrieves data you didn’t know you were looking for. Unlike regular search, which is mostly descriptive, semantic search can be both predictive and prescriptive. Semantic search makes you a whole lot smarter.
Semantic search also uncovers interconnections and relationships between data. Data is combined, compiled and represented in a meaningful way. Your data is enriched, making it more valuable.
Semantic search applications
Here are some cool items we’ve added to our own DISQOVER semantic search platform:
Saved search queries and collaboration: name your search, save it and share it with colleagues. Others can rerun your search, extend it or choose a different path, somewhere along the line, in order to uncover alternative routes for discovery. Collaborating with others on search patterns becomes a lot easier.
Rerun your saved searches. Because data changes all of the time, your research findings will change too. With saved searches, any new data since your last search, will automatically be included in your rerun. That way, you no longer miss out on relevant updates. The saved search path lets you revisit your search on a later date and rerun, resume or change it as you see fit.
Visualize data. The big bang of big data makes deriving insights hard. Visualization helps to better understand search results and facilitates telling a better data story. As your search progresses, our DISQOVER platform automatically updates the search result visualizations while new search criteria are offered for additional refinement. By simply adding or removing search filters, you can zoom in or out on the findings.
Depict the source. Instead of just giving you a search result list, we also create compiled content pages with data from different sources. But because it may be worthwhile to know which data comes from which source, we color code each part. That way, as a (re)searcher, you can define which information is more relevant or reliable, or which sources you would like to research further.
“The Semantic Web is not a separate Web but an extension of the current one, in which information is given well-defined meaning, better enabling computers and people to work in cooperation.” Tim Berners Lee
Everybody becomes a data scientist
Semantic search will become a lot more smarter soon. With ever more data becoming available—including also sensory data of where you are and what you’re state of mind is—generating useful search results will continually become more refined. Until then, companies can already create the right context and generate big wins with semantic search. Semantic search makes complex searches available to all, turning everyone into a data scientist.
Want to know more about our semantic search platform DISQOVER, visit our website or reach out to me ([email protected]).
ONTOFORCE DISQ|OVER Roadmap Nov 2015 Read blog post here: http://goo.gl/1cxmgP
Co-create your product roadmap through user group meetings!
What is it, do you think, that makes you product stand out? One of the best ways to find that out is by simply asking your customers. And that’s what we did.
Mid-September 2015, we went to Harvard Medical School to sit down with a group of experienced users of our product DISQOVER. The goal: find out what they like about DISQOVER and what they believe is needed next. In short: we asked a group of 9 experienced and very active users of DISQOVER - mainly researchers and data scientists - to co-create our product roadmap.
Here’s how we approached our user group meeting:
Firstly, we set the scene: we explained the users where we are today, what the latest features of our product are and what’s next in the pipeline.
Then, we asked each participant to write down on a post-it her/his top 4 functionalities and top 4 databases that (s)he would like to see in DISQOVER.
Next, everyone posted her/his ideas on a wall. We clustered like-minded ideas and concepts to examine further what could be put into development.
To finish of the meeting, we asked the attendees 1) whether the session was valuable to them and 2) whether they would recommend DISQOVER to other potential users.
This feedback has now been added to our product roadmap. We’re still reviewing some timelines, but overall priorities have been set:
“With the addition of cell lines, antibodies etc. I would also be inclined to recommend to researchers in R&D” Corporate Strategy Expert
“Yes, other R&D institutes and large organizations can use this, like MIT labs, Harvard etc.” MD
Tips for user group meetings
User group meetings are a great tool to generate business insights. Here are some general insights we took away from this session:
Chose experienced users: bring together a group of diverse but very experienced users. That way, you quickly get pinpointed requests. It’s better to avoid very generic requests that could be interpreted in various ways.
Create the right setting and clearly guide people. Tell participants exactly what it is you expect from them, and in what format. Stay focused and don’t stray from your objective.
Provide feedback back: facilitate interaction, join in the discussion and afterwards, send the resulting feedback to the users. That’s very important. Give them an overview of the ideas that were covered and what your next step will be. Even if it is not explicitly decided yet, underline that as well. People can handle a postponed decision as long the reason behind it is clearly explained.
Take the actions on board: user group feedback is not arbitrary; you have to be willing to take at least some of it on board. If not, you might as well not hold user group meetings.
Don’t jump in blindly: make sure you already have a good understanding of the concerns of your users. If you’re completely surprised by some of the suggestions, than you haven’t been in touch with your users well enough. The outcome should not be a complete overhaul of your product, but rather incremental updates.
What’s next?
This first user group meeting delivered great insights that help us build our product roadmap. But at the same time, it’s also reassuring that the exercise did not uncover any major discrepancies between us and our customers. This tells us that we’re on the same frequency and level as our users.
We are now actively using this to build our product roadmap. After all, when people take the time to provide you with feedback, it’s only right to thank them by taking their comments on board. We’re also reviewing whether we can hold more regular user group meetings using a webinar-like format. That way, we can have an even broader and more diverse user group. Look out for future sessions on this blog and our website.
Was it Henry Ford who said…
And yes, I know, if Henry Ford had asked his potential customers what product development they wanted, they probably would have said ‘faster horses’. But, jokes aside, I believe that with DISQOVER, we’re already passed that stage. We are changing the way search is happening and that is already quite disruptive. What we need now, is not the next new big disruption. No, we now need to develop our product further to meet the key requirements of our key target groups even better. And that’s done through little steps, not big leaps.
Getting smarter with semantic search
How well is data and information management handled at your company? Are you using Big Data? Have you heard of semantic search? These were some of the questions we asked people at the Knowledge For Growth 2015 convention (May 2015). As a semantic search company, we learned that there’s still some education to be done around it. But, looking at it positively, semantic search is considered to be a highly relevant asset for many people within the life sciences industry. Here are the results of our survey.
Our hostesses looking for respondents.
The information and data age The Knowledge For Growth 2015 convention in Ghent welcomed 1100 attendees, and we were able to get feedback from 127 people in total (+/- 10% of attendees). When asked ‘how well is your company managing healthcare and life sciences information today?’, 47% of respondents stated that information is managed `well’ to `very well’, while 42% indicated that it is `not handled well’ to `quite well’. Which is quite shocking really, as the life sciences industry is highly dependent on properly unlocking information to fuel innovation. A point made also by Peter Piot in his morning keynote speech, when he talked about data and information as a driver for life sciences.
The attendees at the convention are very active and fervent searchers for information. 46% of the respondents spend more than half an hour each day searching for information.
With so much search activity going on, improving the accuracy and speed of search results can have a dramatic impact on overall productivity. The respondents acknowledged this: 43% of them believed that improved search functionalities could improve productivity by 20 to 50 per cent. Fourteen per cent considered the increase in productivity to be even more than 50%.
Democratizing data Because data and information disclosure is so important, we asked people how easily accessible this data is. While 35% of respondents indicated that most people within their company have data access and that they can manage the data themselves, the other 65% indicated that they are limited in some form or other to access the data.
In order to fuel innovation, though, step one is to have unrestricted, ready access to the data. This is often referred to as the democratization of data. A trend that is on the rise in recent years, also with the emphasis on more open innovation and more open collaborations across company borders.
The Big Data frenzy The Big Data hype is far from over but, in practice, there’s still very little that’s truly Big Data driven. Only 15% of respondents stated that the majority of their data activities are Big Data driven or that there is a fully integrated Big Data strategy. But a shocking 45% of respondents stated that there is no Big Data activity whatsoever, while another 12% said that they’re working on it.
Searching semantically One way of mining huge amounts of heterogeneous data is through ‘semantic search’. This terminology, however, doesn’t yet ring a bell for 60% of the people.
When briefly explained what semantic search is, 37% thinks that it would be of great benefit to their business. A percentage that increases to 45% for the people already familiar with semantics.
A semantic future Every industry that is driven by data, is challenged to create more value out of that data. And increasingly, that is literally ‘every’ industry. But limited data access, a lack of data democratization, a lack of Big Data initiatives and poorly designed search capabilities are causing companies to lose money. Technologies such as semantic search can quickly close the gap between ‘searching blind’ and ‘finding relevant results immediately’. Semantic search can separate different meanings, it categorizes them and presents the results in a filtered and clustered manner, so that the most relevant information can be pinpointed quicker and easier. Because of its extreme scalability, it can be applied to a virtually unlimited number of data sources. Semantic search ‘glues’ the relevant data together as Linked Data in order to generate more meaningful insights. Try out DISQOVER, our semantic search technology, for free for 14 days. After all, the best way to find out what semantic search can do for you and your company is to try it out.
About the survey: the data used in this blog was collected via a survey during the Knowledge For Growth 2015 convention (May 2015) at the International Conference Center in Ghent, Belgium. There were approximately 1,100 attendees from hundreds of different life sciences organizations. Two hostesses roamed the convention’s floor with iPads (and printed survey forms) to capture the feedback. Attendees were approached randomly. A total of 127 people completed the survey and were offered a free smoothie at the ONTOFORCE stand in return.
Every respondent was offered a refreshing and energizing smoothie.
ISSCR2015 Focus Session in Stockholm on hiPSC Biobanking, Characterization and Distribution
(hiPSC = human induced pluripotent stem cell)
Overall challenges addressed by international initiatives for large scale production of collections of iPSC lines include the establishment of reference lines, standards for quality control and the logistic and legal challenges faced in distributing iPSCs across borders.
The first session addressed the quality control and characterization and **Michael Sheldon **of RUCDR Infinite Biologics called for quality and standards so adoption and use can speed up. Other speakers confirmed this need and confirmed the traction and potential the field of stem cell research has.
“To get to high quality research, we need to have global standards” Michael Sheldon - RUCDR -
The second session focused on the informatics and global coordination of stem cell research.
Where and how to store and find stem cell biobank data is a key question asked. Andreas Kurtz from the Human Embryonic Stem Cell Registry (hESCReg) dug deeper in the registration and access to pluripotent stem cell registries for data comprehension and comparison.
The data required to evaluate a PSC-line by a user are:
Where does it come from?
Is it pluripotent?
Has the data been obtained with informed consent?
How much genotype/phenotype data is available (from donor, cell line, relationships between them)?
What are the generation and cultivation conditions?
Is there feedback on the performance of the line?
Then Richard Pearse form the Harvard Catalyst Group started his session on developing a single point of truth for iPSC information in an open-sourced, semantic web approach using the eagle-i technology. He explained how difficult it is to find the right data and even more to get back to these findings later on … and data is piling up. The use of ontologies to extract the right data and make it interoperable using linked data is the key. Nice example of NYSCF (New York Stem Cell Foundation) mentioned as well as the recent WiCell collaboration. At the end of his talk we thank Richard for the kudo’s towards our DISQOVER app with its “beautiful visualizing linked data” and reference to our joint webinar in July on “The Semantic Web - the future of search.” We look very much forward to that.
“Data is piling up and re-searching it is getting more difficult every day. Making data sharable and consistent is key to help solve that problem.” > Richard Pearse - Harvard Catalyst Group -
Ian Streeter **from EBiSC (European Molecular Biology Laboratory - European Bioinformatics Institute) dived into some real life examples of data and how messy that gets. The EGA (European Genome/Phenome Archive) is one of the example initiatives to link out to the data and make data accessible, definitely something to follow. He also called to have less data access restrictions and more open data.
“The use of ontologies to clean up messy data will lead to much more powerful search capabilities.” Ian Streeter - EBiSC / EGA -
David Panchision closed the session with the challenges and opportunities in resource and data integration from an NIH perspective. General recommendations are:
Resources: centralized sharing of patient and reference lines for wide sharing
**QC/Standards: **validate re-programming and differentiated cell types; validate against other model systems.
Reproducibility: use same protocols and samples across labs
Collaboration and Training: emphasize rapid dissemination of best practices and model after other disciplines such as genetics
Again, the need to aggregate massive amounts of data and being able to mine this, is emphasized together with the use of the eagle-i technology. On top of that there is low hanging fruit leveraging existing resources like the 150K subject samples repository mentioned. And yes, scalable data integration is again key to success. > _“Harmonize accumulated data so we really get return from the investments in biobanking and clinical studies.” > David Panchision - NIMH - > _ > > **Federating biobanks and stem cell lines **was mentioned many times and NIMH focuses on federation of studies also linking biospecimens and experimental data with existing patient records. Great vision and plans harmonizing all that data to end this interesting ISSCR 2015 session.
Our workshop – ONTOFORCE at Knowledge For Growth 2015 – part II
Around 40 participants joined us for our ‘Big Data Workshop: Getting knowledge out of (Big) data’. Hans Constandt, CEO, and Filip Pattyn, Product Manager and Bioinformatician at ONTOFORCE, introduced and demonstrated DISQOVER – our platform to quickly discover insights out of vast amounts of data.
Data discovery is chiefly about next-generation business intelligence and analytics (http://www.gartner.com/newsroom/id/2970917). But all too often, expert researchers depend on data specialists to disclose the relevant data resources. What DISQOVER does, is close the gap between the data specialists and the experts. With our platform, users discover the knowledge themselves. ONTOFORCE’s mission is to let users derive their own insights and DISQOVER is built around this.
The data avalanche
The huge and continually growing amount of data isn’t troublesome, searching the data is. All too often, you only get what you know already. If you don’t know where to search or what to search for, it becomes very difficult to discover the real, hidden value. We therefore need to change the modes and techniques of searching. We need new systems that can quickly integrate new data and which facilitate searching. This enables you to discover insights that you might not even have been looking for.
To do that, DISQOVER uses semantic search, which is still a fairly novel term. When asked who knows about semantic web technologies, only a few hands go up. Consider going on a city trip to Paris, and you want to stay at the Hilton. A Google search on the combination ‘Paris’ + ‘Hilton’ generates 200+ million results, but you need to scroll through quite a few pages of celebrity gossip before you reach some results on the Hilton hotel in Paris. Semantic search separates different meanings, categorizes them and presents the results in a filtered and clustered manner, so that you can pinpoint the most relevant information quicker and easier. The advantage of semantics is the extreme scalability and, thus, it can be applied to a virtually unlimited number of data sources. Relevant data is dynamically ‘glued’ together as Linked Data to lead into meaningful insights.
How does this apply to life sciences? DISQOVER is linked to a wide variety of open data sources. As the speakers in the morning already highlighted, progress comes from open collaboration and open innovation. When looking for, say, an active pharmaceutical ingredient, you may have to search the protein databases, the molecule DBs, the gene DBs, the disease DBs… Today, too many people still have to consult each of these DBs separately, after which different files need to be collated. A typical search use-case such as the one described above, can quickly take up to 50+ hours and 4 weeks of throughput time to deliver the desired results. And much knowledge – such as search queries – gets lost along the way. What DISQOVER does, is glue all these sites and DBs together. On top of that, there’s an intuitive and simple interface to visualize the aggregated data. All very scalable. The time this takes? One hour. The insights at your fingertips.
The proof of the pudding is in the eating
Now, imagine you’re searching companies producing antimetabolite drugs that are involved in phase II clinical trials where drug cancer patients can still enroll, while EGFR must be mentioned and, in addition, you also want to know who are the top authors publishing about these drugs.
Researching this the old way would mean…
- You have to search in different databases, - Digest all the information yourself, - Stitch it all together in a workable format.
The trouble: it’s a hell of a lot of work while the results remain a snapshot at a fixed moment in time. Any updates or changes in any of the consulted databases is out of sight. So if you want to update your information, you have to run the process all over again. Not the most efficient or effective way of searching.
What DISQOVER does is link all the information while keeping track of the search patterns and logic. Often, when we do a classic web search, we start at one place but ultimately end up somewhere else with a lot of open ends. Retracing your steps becomes extremely difficult. While the search logic itself – the reasoning during your search – is valuable and can be modified during a subsequent search.
Time for the rubber to hit the road.
Filip starts up DISQOVER to try the above search example.
- On the start page, there’s no extensive overview of all possible functionalities. Instead, a simple keyword search field is the starting-point. - Filip kicks off the query with the keyword ‘EGFR’. A total of 26 databases are being searched and, almost immediately, the DISQOVER platform shows the different results found across a wide variety of data types. - Each of these data types is a first filter: clicking on ‘clinical trials’, for instance, leads you to the clinical trial results. - Filip then filters further on phase II studies. With every new filter setting, all other filters are instantaneously updated. This prevents filtering combinations from producing no results. - The next filter is the status ‘still recruiting’. A global map then indicates where these clinical trials are happening. - As there are too many results still, one more filter is added, looking for everything related to lung cancer.
Filip meanwhile explains to the audience that the data is being visualized instantly. Although DISQOVER is not a tool for creating dashboards, it automatically includes these along with the actual search results, each containing references to the original sources.
Filip also points out that ONTOFORCE is not a data owner but a data broker. The DISQOVER platform queries open databases. ONTOFORCE continually discusses the merits of unlocking additional databases with new partners. Within DISQOVER, additional databases – be they open, licensed or private – can be added.
- In the meantime, Filip follows the link from clinical trials to drugs. These are the drugs related to the resulting clinical trials. A new series of filters becomes available. What is cool about the tool, is that it automatically adjusts the available search possibilities based on the available criteria. Like gentle nudges offering you opportunities to discover new places where you might not have searched before.
- Filip includes ‘antimetabolites’ as an ATC classification filter.
- The filter that shows all manufacturers contains the first portion of information requested.
An extra neat feature is that you don’t have to visit different websites: DISQOVER already compiles different pieces of content. To make sure the origin of each section is clear, the data can be highlighted with a different color code per individual source.
Filip now switches his attention to retrieving the key authors and publications:
- He follows the link from the resulting drugs to publications.
- To make the result more refined, an additional filter is added, looking only for publications of the last 5 years.
- Automatically, the system has semantically identified the top publishers; one of them is in fact someone from the KULeuven.
All in all, this search took around 15 minutes (including the explanation to the audience). What is extra helpful, is that the search pattern is saved for later use. DISQOVER automatically keeps track of the search pattern as a sort of timeline. Clicking on a step in the search path automatically reproduces a search result. Each adjustment to a previous search step is also stored as a new branch. As such, the thinking path or pattern is stored and you (or any of your colleagues) can reproduce the search to see what was updated since the initial search was made. Just as easily, you can name your search, save it, share it with others, ‘rebranch’ the data, collaborate with peers on search patterns and extend insights accordingly.
Someone in the audience asks: “what exactly do you mean by ‘links’?”
A link is simply a piece of content available somewhere in the vast number of databases that connects two or more data concepts. An example is the connection between a drug and the clinical trial in which the drug is tested. What is cool about DISQOVER is that it also includes `mentions’: the number of times a content item has been mentioned per data type. This is something unique due to the vast amount of data sources covered in DISQOVER.
Combining resources and integrating data
The value of semantic search increases with every additional database that’s added. ONTOFORCE continues to partner with as many different data providers as possible, requesting them to open up their data. ONTOFORCE is working with, amongst others, Harvard Catalyst Group in Cambridge US. They developed the Eagle-I network, which aims to open up biomedical scientific research. The consortium already has 41 universities and research institutions in the US and ONTOFORCE is assisting to bring the platform to Europe. The case of the BCCM/LMBP Plasmid Collection, hosted at Ghent University (UGent) and part of the Belgian Coordinated Collection of Microorganisms (BCCM), clarifies further how additional data sources can be disclosed. This organization already has a searchable catalogue, but it is isolated and not linked to publications. ONTOFORCE assisted in integrating the plasmid catalogue into UGent’s eagle-i platform, which now can be searched semantically, while a referral to the original page remains in place.
Another good example of the value of semantics is applicable to The Antibody Registry. Because there’s no nomenclature used for how to define an antibody, antibody descriptions are notoriously heterogeneous. For researchers it’s extremely hard to know which antibody is the correct one. Through the application of the eagle-I ontology*, relationships between different antibody descriptions and other data types can be established, relevant filters can be defined and synonyms are identified more quickly, making antibody data retrievals much easier.
ONTOFORCE aims to continually simplify its DISQOVER user interface (UI), so that it becomes straightforward for anyone to use. DISQOVER can become the new standardized way to smartly research dozens of different data sources. You don’t need IT people or data scientists to catalogue all new information. It’s about bridging the data gap between research, academics and industry.
In our next blog, we will cover the Q&A that followed our workshop.
* In computer science and information science, an ontology is a formal naming and definition of the types, properties and interrelationships of the entities that really or fundamentally exist for a particular domain of discourse. An ontology compartmentalizes the variables needed for some set of computations and establishes the relationships between them. Source:
http://en.wikipedia.org/wiki/Ontology_%28information_science%29
A report, ONTOFORCE at Knowledge For Growth 2015 – part I
Some events are absolutely great and `Knowledge For Growth 2015’ fitted the bill perfectly. A big crowd (±1,100 people) of highly relevant life sciences people, a wide range of different topics, enthusiastic speakers, 90+ exhibitors, and yes, the food was great too. Here’s our report from K4G 2015.
The importance of biotech
It’s not every day a fair is opened by … a bell. The Euronext Bell Ceremony at 9 o’clock demonstrated the growing relevance of biotech on the Brussels stock market. Biotech’s market value has grown fast these past few years to €15+ billion and I’m sure many of us are looking to add even more value to this.
Peter Piot, Director & Professor of Global Health, London School of Hygiene & Tropical Medicine, was the first to take the stage. He summed up some of the major global health challenges we’re faced with today: ever-more resistant bacteria, insects that are immune to pesticides, climate change, ageing populations, … There are many things we can and must do to remedy these challenges. Professor Piot strongly emphasized the importance of 1) public private partnership models as well as 2) innovation to do this.
“It’s not just about delivery in innovation, it’s also about innovation in delivery.”
Peter Piot, @Knowledge For Growth 2015, keynote presentation, May 2015
Professor Piot had already referred to mobile and smartphones as a means to bring healthcare to people in poorer parts of the world and the second speaker, Young Sohn, President and Chief Strategy Officer at Samsung Electronics, enlarged on that. Samsung, which ships 600 million devices per year, is increasingly looking at connecting all these devices to each other. A reference, of course, to the Internet-of-Things (IoT). This will be highly relevant in delivering personalized, preventive healthcare advice to people.
“Everything we do, everything we touch will have the power of connectivity.”
Young Sohn, @Knowledge For Growth 2015, keynote presentation, May 2015
A big challenge Sohn sees, is that today, data is siloed. And siloed data does not give you many insights. So opening up data and making it more freely available will become increasingly important. Sohn demonstrated this by mentioning a few of the initiatives they support, such as an IoT platform, which enables non-developers to ‘write’ code that interconnects different devices. Many of these applications will also extend beyond healthcare: more data can help, for example, in tackling some of the climate change challenges, such as extreme drought in certain parts of the world.
Droughts and climate change are also high on the agenda of Kemal Malik, responsible for Innovation at Bayer AG, the last of the big companies that still combines pharma, healthcare and crop sciences. The reason: there’s a lot of overlap in the biology of humans and other species. Even the fruit fly shares about 60% of its DNA with humans. Increasingly, learning from different species can generate new insights and new solutions. But to do so, Malik is convinced companies need to collaborate with other parties. To achieve this, Bayer launched several open innovation projects and collaborator spaces where start-ups can work at Bayer offices. The days that big companies can do everything on their own are gone: not all the smart people work for your company and, increasingly, small companies can do more on their own. Many innovations can happen without big funding or investments.
“We can’t get the science right alone, we need partners.”
Kemal Malik, @Knowledge For Growth 2015, keynote presentation, May 2015
The importance of data in research
The three plenary speakers at the morning session all had one message in common: the importance of data in research is growing by the day and embracing the data will be the key driver to solve many of the challenges we face. Not just when it comes to medicines, but also in agriculture, improved research methods can speed up the discovery of solutions. Preventive health, digital health, personalized medicines, … many of these innovations are data driven.
“The data revolution is driving more and more of what we’re doing.”
Peter Piot, @Knowledge For Growth 2015, keynote presentation, May 2015
All speakers also emphasized who’s at the center of all activity: people. And that’s also precisely why we started ONTOFORCE. To help patients. To help people find relevance in an ever-growing amount of data.
That was also the topic of our own workshop. And the topic of PART II of our blog on Knowledge for Growth 2015.
Hackathon at SWAT4LS Berlin 2014
The third day of the Semantic Web Applications and Tools for Life Sciences (SWAT4LS) meeting and workshop in Berlin on December 11th, was completely dedicated to a hackathon organized at the Konrad-Zuse-Zentrum für Informationstechnik Berlin (ZIB), Computer Science Campus, Freie University Berlin.
We joined with four people from ONTOFORCE to meet like-minded semantic web and linked open data people, to taste what’s going on in the field and to seek for help for our ‘challenge’. We’re looking for solutions to deal with the author issues in PubMed abstracts. Author names in scientific publications are in most cases difficult to link to physical persons due to ambiguities with namesakes, inconsistent usage of middle name initials, missing data etc.
After introducing the challenge with some real life examples, some participants got their teeth into it. We suggested to start with known person-publication links provided by physical persons and gathered by the ORCiD.org initiative. At the end of the day, three interesting proposals were presented and the audience voted for James Malone’s idea as the best proposal. He was awarded an iPad mini for his efforts. The runner-up proposal by Robert Hoehndorf received only one vote less.
Below some pictures of the participants presenting their solutions.
Hans Constandt, our CEO, decided to extend the challenge till the end of December 2014 to allow others to participate. We will offer another iPad mini if more elaborated and improved suggestions are committed in our open github repository by Tuesday Dec 30th 17:00 CET. Pls share the message to get more people involved if interested.
We’re awaiting the final results and will dive into the implementation of the proposals in our DISQOVER product.
Thanks for all the proposals and thanks to the SWAT4LS organizers, Filip, Andra, Ewout & Hans
Day #1 Digital Tech Summit London 2014
Today's first Digital Tech Summit was a very inspiring day where I met some old and quite some new interesting people from the International Venture Club.
It started with some startup pitches by Intesa Sanpaolo, then a great networking lunch at organized by PICTET at the Swan bar/restaurant, an afternoon with some really great round tables and then a networking event at WAYRA. All very well organized. I am impressed how many folks I could easly meet and talk to ... guess I pitched ONTOFORCE & DISQOVER many times but I also listened to the advise and lessons learned.
Walking back alone to the hotel after a long day in rainy London to order all my thoughts and capture the connections I need to follow up - IBM Watson, HealthX, QualComm, Capricorn, Newion, 247Invest, eVenturesClub, PICTET, MobiCap, idinvest, High-Tech Gründerfonds EuroNext for SME's, WAYRA ... I passed by the Wellcome Trust Center ... and yes I was silent and enjoyed the inspiration.
Nothing need to be said here, just take a look at the pictures I took ...
I very much look forward to tomorrow and already thank the organizers big time for the experience and connections.
Thx & cheers, Hans
Inspiring talk by Noel Slangen with some take-aways on entrepreneurship
Today I was inspired by a talk by Noel Slangen … communication specialist, entrepreneur and spin doctor of many very influential people … next vacation I will definitely read one of his books.
The last 4 months we worked very hard in our company to take a next big step in professionalization expanding the team with more stable HR, setting up better accountancy & reporting, two strong domain experts, first user feedback, IP transfer and much more. Innovation at work in a start-up and to me it feels like crossing a chasm.
But back to the talk of Noel Slangen and my take-aways which are so aligned to our last months mentioned above.
There is a clear difference with entrepreneurs and managers and the latter are taken a lot for the first. The passion, daring to take risks and putting money on the table is different compared to good management which, of course, is also needed. Entrepreneurs who fail should not be blamed for it but honored. The model of entrepreneurs in residence, seemingly applied more in the US, should also be evangelized more in Belgium. If we would fail at ontoforce, which I expect not, we still have learned so much that (1) we will sure do better next time and (2) it definitely feels like earning a real MBA, in the trenches. In which company can you learn and apply so much about IP, accountancy, budgeting, financial planning, marketing, sales, HR, development, licensing, user agreements, funding, raising money, negotiating … all such a short period. It is great to be in a start-up!
Another lesson I took from Noel’s talk was to be able to get emotionally disconnected from your baby, your idea, your start-up … look at it from the outside. Great tip to think/ask how somebody else talks about or introduces your company … and how you’d like them to talk about your company. If possible, we at ontoforce loved to be recognized for top team, top technology but more over pragmatic implementors with a focus on the end user transforming the way healthcare and life sciences uses information and big data at work. Sure, we still have to work hard to get there but we feel we’re on track!
I won’t go in detail but I loved other aspects of the talk explaining that in stress or busy times quality of work is higher and better decisions are made in regards of times where people have more time … Couldn’t agree more! The worst decision is not making one…
And last thing I took away is the fact that advisers have such an important role in a company. They help you look from the outside, with fresh and challenging view on your company and product. That’s why I’d like to end with a thank you for the great advise we got form our board members and advisers like Luc Vauterin, Luc Burgelman, Bernard Munos, Filip Coenen, Koen Schrever, Frederik Vanmarsenille and all other support from iMinds, MMLab, VIB, VOKA, IPPorta, Agentschap Ondernemen, IWT, VOKA, Belfius, Gartner, former colleagues, friends … too many to name but very glad to have your backup, advise and support. And yes, start-ups should get more advise from the beginning and not be ashamed to pay for that as it pays back most of the times.
Thanks for the invitation by Deloitte today. Even if start-ups don’t have the money (yet), I am convinced they still can engage from the beginning via initiatives like BRYO, BizzIdee, Enterprize, BattleOfTalents and others to get ‘free’ advise to get started.
Special thx to Noel Slangen for this quick sharing of some of his lessons learned, motivating us to keep the entrepreneurial spirits going.
Cheers! Hans
Great feedback on demo's & getting ready for the market - BioTrinity in Newbury UK
Last week Marie and I were attending BioTrinity in NewBury UK. A real nice venue and very well organized seminar.
The main tendancy was around venturing & inlicensing with a good balance of biotech, big pharma.and venture capital representatives. A panel discussion "Innovative Financing and Deferred Consideration, Essential Parts of Deal Terms?" chaired by John Carroll from FierceBiotech and panellists David Colpman (Shire Pharmaceuticals), Tim Herpin(AstraZeneca), Stewart Kay (GlaxoSmithKline), Patrick Verheyen (Johnson & Johnson) and Scott Cuthill (Ipsen Biopharm Ltd) highlighted that. There was some moemntum when what was evangelized by the big parties and what happened in reality with the engagement models still show discrepencies. But the momentum is there, now.
We met quite some folks from biotech and pharma and got great feedback on our demo's. Looks the workshop confirmed we are ready for the market. Our dev team is prepping that together with sales and marketing to make it happen.
Next to that our tool is really getting momentum not only with visitors at our booth but also with a pharmaTV interview, follow up and a potential editorial in Pharma publications (IPI).
The team has a lot to follow up which is a good thing and made this a successful business trip.
Cheers, Hans
Empowered Patient Advocacy Groups @BioConvention 2013 Chicago
Peter Verrykt and I attended BIO International Convention on April 21-25, 2013 in Chicago together with a FlandersBio mission with the best of the best from Flanders Biotech.
It started off well with a great networking dinner organized by FIT (Flanders Investment & Trade - http://www.flanderstrade.be/) and FlandersBio. Great connections and insights and the BioConvention didn’t start yet. And always great to see former colleagues and friends with formal and less formal chats.
Monday started well with some good panels and hot items as patient advocacy groups and giving access to the voice of the patients. Great to see how Eli Lilly is demonstrating how to do this. A panel on Wednesday about modernizing clinical trials confirmed this approach and how patients engage using social media. The growing data, aka pharmageddon, need to be transformed in better insights. Three big pharma representatives again talked about the urgency of opening and sharing data. Clearly a confirmed trend. Real world evidence, open innovation in biopharmaceutical R&D in these changing times get embraced by all big pharma: AstraZeneca and JNJ showcased some examples and explained future plans: “By sharing new ideas and enabling scientific innovation to cross boundaries between companies, academia, government and non-profit organizations, we can accelerate new ideas into innovative medicines.”
There was also a very nice Flemish panel with ThromboGenics, Galapagos & Complix/Ablynx: great stories of successful entrepreneurship & top science in Belgium. This was also confirmed in many chats during the whole convention, the Belgian pavilion was crowded and the top ranking of VIB (Flemish Institute of Biotechnology) is recognized and respected. The Belgian night downtown was amazing: 850 visitors, great ambiance, good networking and fun. Not to forget the Belgian fries and beer. J
The FierceBiotech exec meeting gave great insights and showed again the need for big data analytics and data driven drug discovery. The numbers of the pharma conundrum were noted again: less drugs and costs still rising. The next panel discussion moderated by Ryan Mc Bride from FierceBiotech again discussed the need for being able to analyze big open data. Gunaretnam (Guna) Rajagopal, VP & CIO Research, Bioinformatics & External Innovation at Janssen, together with Marc Berger, Vice President Real World Data and Analytics at Pfizer gave some of their views on how they will help transform the business. A good quote to finalize: "At the end we'll end up in an open source data world and things will speed up by who can analyze this best. “ We’re looking forward to assist.
Cheers! Peter & Hans
And welcome Nicola ! Our new data scientist !
BioVision 2013: it's all about the patient & collaborative intelligence.
Peter and I are just back from three days BioVision in Lyon with excellent organization, good presentations, great food and active networking where we met passionate key opinion leaders, influencers and new partners.
There was a lot to do around 'the patient in the center' and how to enable them to actively participate from the beginning. Patients can be powerful partners in their own care, so how do we harness this potential? Privacy is something that takes time with legal and politicians but patients are engaging more and more. Patients want to share as long as they are in control of their data. At the end, the patient wants to get cured quickly and with no side effects if possible which is personalized medicines.
From a technology perspective, big data and user design were hot again. How can we easily combine and aggregate data? How can all this data be used easily? Mobile phones and gamification were demonstrated in successful showcases.
Amy and Claire gave a great example of the tools of the future. By playing EyeWire, you help map the retinal connectome and contribute to the neuroscience research conducted by Sebastian Seung's Computational Neuroscience Lab at MIT.
Larry Chu explained real life examples how smart people used technology with disruptive models of innovation applied.
Sharon from GeneticAlliance, a world’s leading nonprofit health advocacy organization committed to transforming health through genetics and promoting an environment of openness centered on the health of individuals, families, and communities. They include more than 1,000 disease-specific advocacy organizations, as well as thousands of universities, private companies, government agencies, and public policy organizations. The network is a dynamic and growing open space for shared resources, creative tools, and innovative programs.
Marja Makarow talked about a eHealth platform taking off in Finland. Peter Verhaegen gave some nice m-Health examples. The IMI initiatives EMTRAIN, SafeSciMET, PharmaTrain, eTRIKS … to share, train and institutionalize patients. Roberto Santoro, Stephen Friend and many other inspirational talks and panel sessions.
It was clear we need to empower patients' interactions more so collaborative intelligence comes into action and crowdsourcing is possible to disrupt current broken pharma model. Rudi Pauwels concluded nicely "let's build sustainable healthcare together". We're joining this mission!
Peter & Hans
CTMM TraIT Symposium in Utrecht - Big Data Needs Big Ideas (Eric Perakslis) -
Last Tuesday March 19, Peter and myself had an inspiring afternoon at the CTMM Centre for Translational Molecular Medicine (CTMM) TraiT (Translational IT) symposium (http://goo.gl/0TQya) in Utrecht (Netherlands). The emphasis was on the “connect” word, connecting and collaborating with a scalable and sustainable translational ICT platform with the patient in the center. How can we better connect phenotype(aka symptoms) with disease biology where the patient can benefit from? And the need is there and now! I appraciated the analogy with the holy grail as the quest for translation information integration for personalized medicines indeed needs believe, courage and passion to bypass many failures but keep faith in the value for the patients. The audience and myself appreciated Scott Wagers explaining the IMI eTRIKS project. I’m very happy to see translational colleagues pursuing the quest and IMI (Innovative Medicine Initiative) mentioned as one of the places to collaborate. The closing note by Hans Stam, Managing Director at the Dutch Heart Foundation, was spot on. The patient view: how to use my research data? There is more need to really collaborate across the boundaries of what we’re used to. And the patient doesn’t give a *peep* about privacy. Regulators and politicians do … What’s wrong? We really need to help the patients, to get them organized and make use of the wealth of data and technology enablers. And to be successful, we need to keep doing this and demonstrate the impact in quality of life and cost saving so we keep and grow the momentum. We are acvtively engaging in this mission and if you want to join us, let us know!
Team meetings in the garage with the new demo presented by Peter_v.